A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. [electronic resource]
- PLoS pathogens Nov 2008
- e1000226 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1553-7374
10.1371/journal.ppat.1000226 doi
Binding Sites Coagulase--metabolism Crystallography, X-Ray Drug Design Fibrinogen--metabolism Models, Molecular Peptides--chemical synthesis Protein Binding--drug effects Staphylococcal Infections--drug therapy Staphylococcus aureus